Focus on Bharti Airtel, BoI, HPCL, MTAR Tech, PI Industries, Ind Swift Lab, MOIL, IndiaMart, IG Petrochem, Intellect Design

Stocks that will see action today (November 2)

PI Ind said the purchase consideration of Rs 1,530 crore will be paid in all-cash and funded from the proceeds of the completed QIP and internal accruals

Ind Swift Labs tanks 16% on selling API business to PI Industries

Here’s an ET NOW exclusive. ET NOW’s Ajaya Sharma learns from his sources that Agrochem major PI Industries is scouting for a meaningful acquisition in the pharma space and has Ind-Swift Labs on his radar. PI Industries had recently raised Rs. 2000cr via the QIP route and had earmarked the fund raise for acquisitions in the pharma space. As per sources, PI Industries is in active talks with Ind Swift Labs for a promoter stake buyout and had recently raised 2000cr via QIP marked for buyouts. The targeted company Ind-Swift Labs is a global manufacturer of APIs, Intermediates and formulations with promoter stake currently at 42%.

Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3

Subscribe Now To Our Network Channels :-
Times Now  : http://goo.gl/U9ibPb
The NewsHour Debate : http://goo.gl/LfNgFF

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

DET090221 04 video of PI Industries Exclusive tv report for digital 1024

The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.

BRIEF-Ind Swift Ltd Reports Sept-Qtr Loss - Investing.com India

BRIEF-Ind Swift Ltd -Gets EIR From USFDA For API Making Facility At Derabassi, Punjab - Investing.com India

Read BRIEF-India's Ind Swift To Consider & Approve Lease/Sale Of Its Units No. III & IV  By Reuters

BRIEF-India's Ind Swift To Consider & Approve Lease/Sale Of Its Units No. III & IV  - Investing.com India


The USFDA has cleared this inspection without any 483 observations.

USFDA clears inspection at Ind Swift Lab Derabassi unit without observations

The promoters of Chandigarh based drug maker Ind-Swift Laboratories are in exit mode. ET NOW's @ashwinmohansays joins in with more #EXCLUSIVE details. Alert - Ind Swift Labs produces 50 API's in ...

Ind-Swift Laboratories in exit mode | Exclusive

Ind Swift, Sterling Bio, Koran etc are the stocks showing strength in the market. Watch this special segment and get to know more here.Zee Business is one of the leading and fastest growing Hindi...

Ind Swift, Sterling Bio, Koran etc are the stocks showing strength in the market

First Trades on Dalal StreetNifty Down 5.30 =0.10%, Sensex Down 23.72= 0.14%, Rel Power Down 0.45%, Tata Power Up 0.46%, Ind Swift Up 0.20%,Fuel Prices - Diesel rates may rise by Rs 4-5/ lt after...

First Trades on Dalal Street

Ind Swift Labs - Got approvals for 5 products from USFDA

Price return has been average, nothing exciting

Performance

Can be considered moderately valued vs the market

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Ind-Swift Limited is a manufacture of formulations. The Company is a pharmaceutical company, which offers finished goods dosage, active pharmaceutical ingredients (APIs) and herbal products.

Ind Swift Ltd

Ind Swift Ltd

Scorecard

News & Opinions